Metformin protective against colorectal cancer?

Metformin is a widely used treatment for type 2 diabetes mellitus, but previous research suggests it also prevents colorectal cancer. Researchers conducted a double-blind, placebo-controlled multicentre trial in 151 patients without diabetes mellitus who had previously undergone removal of one or more colorectal adenomas or polyps. Patients treated with low-dose metformin for 1 year were found to have fewer ademomas or polyps than controls, with no severe adverse effects observed. Larger and more long-term trials are now required.


  1. 1

    Higurashi, T. et al. Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial. Lancet Oncol. (2016)

Download references


Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ridler, C. Metformin protective against colorectal cancer?. Nat Rev Gastroenterol Hepatol 13, 250 (2016).

Download citation


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing